Discover how a 5-day fasting-mimicking diet revolutionizes type 2 diabetes management, reducing medications and improving ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

1.Proactively identify barriers to medication adherence, ... Prior to AllazoHealth, he served as vice president of strategy and vice president of product management at CVS Health, ...

Employees enrolled in HDHPs are often the most exposed to price volatility, making pharmacy strategy a critical lever in any ...

How digital technologies and behavioural science create adherence ... strategies to use behavioural science to build patient support programmes that create healthy habits and medication adherence.

Lon G. von Hurwitz, who will serve as chief strategist and senior advisor, brings 30-plus years of leadership experience in ...

Specific factors, including deep sleep and daytime urinary control, are associated with treatment-responsive nocturnal enuresis among children.

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...

WeightWatchers Clinic Members Can Access FDA-Approved Wegovy® for $299 in July, a $200 Savings Offer to Improve Access as WeightWatchers’ Trusted, Science-Backed Approach Continues to Lead the Industr ...

Glucagon-like peptide-1 (GLP-1) injections such as Wegovy (semaglutide) and Zepbound (tirzepatide) are the most effective weight-loss medications available today. Oral GLP-1 pills, such as ...